Amylyx prices upsized 14,090,000-share follow-on at $35.5/share for $500.2 million gross proceeds
Reuters2026/08/20 03:06- Amylyx priced an upsized underwritten public offering of 14,090,000 common shares at USD 35.5 per share.
- Gross proceeds expected at about USD 500.2 million before fees, excluding any underwriters’ option exercise.
- Underwriters hold a 30-day option to buy up to 2,113,500 additional shares.
- Net proceeds earmarked for avexitide pre-commercial work, R&D, working capital, general corporate purposes.
- Closing expected on or about Aug. 21, 2026, subject to customary conditions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas: Meta (META.US) has promising prospects for monetizing computing power, with potential beyond advertising to include "cloud" opportunities
After meeting with the company's management, investment institution BNP Paribas believes that Meta Platforms' computing power assets have considerable commercial monetization potential.
Dow Jones Top Energy Headlines at 12 AM ET: U.S. Crude Oil Stockpiles Post Weekly Increase | Oil ...
UBS raises Palo Alto Networks' target price to $390
BCV H1 FY26 net profit rises 5% to CHF 225 million; revenue climbs 2% to CHF 593 million
Crypto prices
More
